261 related articles for article (PubMed ID: 33909646)
1. Seroprevalence of anti-SARS-CoV-2 antibodies in a cohort of New York City metro blood donors using multiple SARS-CoV-2 serological assays: Implications for controlling the epidemic and "Reopening".
Jin DK; Nesbitt DJ; Yang J; Chen H; Horowitz J; Jones M; Vandergaast R; Carey T; Reiter S; Russell SJ; Kyratsous C; Hooper A; Hamilton J; Ferreira M; Deng S; Straus D; Baras A; Hillyer CD; Luchsinger LL
PLoS One; 2021; 16(4):e0250319. PubMed ID: 33909646
[TBL] [Abstract][Full Text] [Related]
2. Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients.
Luchsinger LL; Ransegnola BP; Jin DK; Muecksch F; Weisblum Y; Bao W; George PJ; Rodriguez M; Tricoche N; Schmidt F; Gao C; Jawahar S; Pal M; Schnall E; Zhang H; Strauss D; Yazdanbakhsh K; Hillyer CD; Bieniasz PD; Hatziioannou T
J Clin Microbiol; 2020 Nov; 58(12):. PubMed ID: 32917729
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays.
Allen N; Brady M; Carrion Martin AI; Domegan L; Walsh C; Houlihan E; Kerr C; Doherty L; King J; Doheny M; Griffin D; Molloy M; Dunne J; Crowley V; Holmes P; Keogh E; Naughton S; Kelly M; O'Rourke F; Lynagh Y; Crowley B; de Gascun C; Holder P; Bergin C; Fleming C; Ni Riain U; Conlon N;
Microbiol Spectr; 2021 Oct; 9(2):e0039121. PubMed ID: 34585976
[TBL] [Abstract][Full Text] [Related]
4. Validation of Commercial SARS-CoV-2 Immunoassays in a Nigerian Population.
Ige F; Hamada Y; Steinhardt L; Iriemenam NC; Uwandu M; Greby SM; Aniedobe M; Salako BL; Rangaka MX; Abubakar I; Audu R
Microbiol Spectr; 2021 Oct; 9(2):e0068021. PubMed ID: 34612691
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 Serologic Assays in Control and Unknown Populations Demonstrate the Necessity of Virus Neutralization Testing.
Rathe JA; Hemann EA; Eggenberger J; Li Z; Knoll ML; Stokes C; Hsiang TY; Netland J; Takehara KK; Pepper M; Gale M
J Infect Dis; 2021 Apr; 223(7):1120-1131. PubMed ID: 33367830
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of SARS-CoV-2 in blood donors from the Lodi Red Zone and adjacent Lodi metropolitan and suburban area.
Cassaniti I; Percivalle E; Sarasini A; Cambiè G; Vecchio Nepita E; Maserati R; Ferrari A; Corcione A; Di Martino R; Bonetti A; Di Napoli A; Ferrari G; Baldanti F
Clin Microbiol Infect; 2021 Jun; 27(6):914.e1-914.e4. PubMed ID: 33677083
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a Surrogate Enzyme-Linked Immunosorbent Assay-Based Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) cPass Neutralization Antibody Detection Assay and Correlation With Immunoglobulin G Commercial Serology Assays.
Nandakumar V; Profaizer T; Lozier BK; Elgort MG; Larragoite ET; Williams ESCP; Solis-Leal A; Lopez JB; Berges BK; Planelles V; Rychert J; Slev PR; Delgado JC
Arch Pathol Lab Med; 2021 Oct; 145(10):1212-1220. PubMed ID: 34181714
[TBL] [Abstract][Full Text] [Related]
8. Low Seroprevalence of SARS-CoV-2 in Rhode Island blood donors during may 2020 as determined using multiple serological assay formats.
Nesbitt DJ; Jin DP; Hogan JW; Yang J; Chen H; Chan PA; Simon MJ; Vargas M; King E; Huard RC; Bandy U; Hillyer CD; Luchsinger LL
BMC Infect Dis; 2021 Aug; 21(1):871. PubMed ID: 34433423
[TBL] [Abstract][Full Text] [Related]
9. Estimating SARS-CoV-2 Seroprevalence in Canadian Blood Donors, April 2020 to March 2021: Improving Accuracy with Multiple Assays.
Tuite AR; Fisman D; Abe KT; Rathod B; Pasculescu A; Colwill K; Gingras AC; Yi QL; O'Brien SF; Drews SJ
Microbiol Spectr; 2022 Feb; 10(1):e0256321. PubMed ID: 35196819
[TBL] [Abstract][Full Text] [Related]
10. Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City.
Stadlbauer D; Tan J; Jiang K; Hernandez MM; Fabre S; Amanat F; Teo C; Arunkumar GA; McMahon M; Capuano C; Twyman K; Jhang J; Nowak MD; Simon V; Sordillo EM; van Bakel H; Krammer F
Nature; 2021 Feb; 590(7844):146-150. PubMed ID: 33142304
[TBL] [Abstract][Full Text] [Related]
11. Single-Dilution COVID-19 Antibody Test with Qualitative and Quantitative Readouts.
Bortz RH; Florez C; Laudermilch E; Wirchnianski AS; Lasso G; Malonis RJ; Georgiev GI; Vergnolle O; Herrera NG; Morano NC; Campbell ST; Orner EP; Mengotto A; Dieterle ME; Fels JM; Haslwanter D; Jangra RK; Celikgil A; Kimmel D; Lee JH; Mariano MC; Nakouzi A; Quiroz J; Rivera J; Szymczak WA; Tong K; Barnhill J; Forsell MNE; Ahlm C; Stein DT; Pirofski LA; Goldstein DY; Garforth SJ; Almo SC; Daily JP; Prystowsky MB; Faix JD; Fox AS; Weiss LM; Lai JR; Chandran K
mSphere; 2021 Apr; 6(2):. PubMed ID: 33883259
[TBL] [Abstract][Full Text] [Related]
12. Assessment of serological assays for identifying high titer convalescent plasma.
Farnsworth CW; Case JB; Hock K; Chen RE; O'Halloran JA; Presti R; Goss CW; Rauseo AM; Ellebedy A; Theel ES; Diamond MS; Henderson JP
Transfusion; 2021 Sep; 61(9):2658-2667. PubMed ID: 34216156
[TBL] [Abstract][Full Text] [Related]
13. A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations.
Grzelak L; Temmam S; Planchais C; Demeret C; Tondeur L; Huon C; Guivel-Benhassine F; Staropoli I; Chazal M; Dufloo J; Planas D; Buchrieser J; Rajah MM; Robinot R; Porrot F; Albert M; Chen KY; Crescenzo-Chaigne B; Donati F; Anna F; Souque P; Gransagne M; Bellalou J; Nowakowski M; Backovic M; Bouadma L; Le Fevre L; Le Hingrat Q; Descamps D; Pourbaix A; Laouénan C; Ghosn J; Yazdanpanah Y; Besombes C; Jolly N; Pellerin-Fernandes S; Cheny O; Ungeheuer MN; Mellon G; Morel P; Rolland S; Rey FA; Behillil S; Enouf V; Lemaitre A; Créach MA; Petres S; Escriou N; Charneau P; Fontanet A; Hoen B; Bruel T; Eloit M; Mouquet H; Schwartz O; van der Werf S
Sci Transl Med; 2020 Sep; 12(559):. PubMed ID: 32817357
[TBL] [Abstract][Full Text] [Related]
14. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard.
Saeed S; O'Brien SF; Abe K; Yi QL; Rathod B; Wang J; Fazel-Zarandi M; Tuite A; Fisman D; Wood H; Colwill K; Gingras AC; Drews SJ
PLoS One; 2021; 16(9):e0257743. PubMed ID: 34555095
[TBL] [Abstract][Full Text] [Related]
15. Emergency response for evaluating SARS-CoV-2 immune status, seroprevalence and convalescent plasma in Argentina.
Ojeda DS; Gonzalez Lopez Ledesma MM; Pallarés HM; Costa Navarro GS; Sanchez L; Perazzi B; Villordo SM; Alvarez DE; ; Echavarria M; Oguntuyo KY; Stevens CS; Lee B; Carradori J; Caramelo JJ; Yanovsky MJ; Gamarnik AV
PLoS Pathog; 2021 Jan; 17(1):e1009161. PubMed ID: 33444413
[TBL] [Abstract][Full Text] [Related]
16. Pre-pandemic antibodies screening against SARS-CoV-2 and virus detection among children diagnosed with eruptive fevers.
Najimi N; Tajount L; Regragui Z; Remz C; Ait-Lhaj-Mhand R; Kadi C; Belayachi L; Seghrouchni F; Nadia Dakka ; El Hassani RA; Elharti E; Oumzil H; Bakri Y
Int J Immunopathol Pharmacol; 2024; 38():3946320241260633. PubMed ID: 38836458
[TBL] [Abstract][Full Text] [Related]
17. An Assessment of Serological Assays for SARS-CoV-2 as Surrogates for Authentic Virus Neutralization.
Wohlgemuth N; Whitt K; Cherry S; Kirkpatrick Roubidoux E; Lin CY; Allison KJ; Gowen A; Freiden P; Allen EK; ; Gaur AH; Estepp JH; Tang L; Mori T; Hijano DR; Hakim H; McGargill MA; Krammer F; Whitt MA; Wolf J; Thomas PG; Schultz-Cherry S
Microbiol Spectr; 2021 Oct; 9(2):e0105921. PubMed ID: 34704832
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal assessment of SARS-CoV-2 IgG seroconversionamong front-line healthcare workers during the first wave of the Covid-19 pandemic at a tertiary-care hospital in Chile.
Iruretagoyena M; Vial MR; Spencer-Sandino M; Gaete P; Peters A; Delgado I; Perez I; Calderon C; Porte L; Legarraga P; Anderson A; Aguilera X; Vial P; Weitzel T; Munita JM
BMC Infect Dis; 2021 May; 21(1):478. PubMed ID: 34039287
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of SARS-CoV-2 (COVID-19) exposure in pet cats and dogs in Minnesota, USA.
Dileepan M; Di D; Huang Q; Ahmed S; Heinrich D; Ly H; Liang Y
Virulence; 2021 Dec; 12(1):1597-1609. PubMed ID: 34125647
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Three Quantitative Anti-SARS-CoV-2 Antibody Immunoassays.
Chapuy-Regaud S; Miédougé M; Abravanel F; Da Silva I; Porcheron M; Fillaux J; Diméglio C; Izopet J
Microbiol Spectr; 2021 Dec; 9(3):e0137621. PubMed ID: 34937195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
